Cargando…
Framework for Implementing Individualised Dosing of Anti-Cancer Drugs in Routine Care: Overcoming the Logistical Challenges
SIMPLE SUMMARY: Many anti-cancer drugs are prescribed at a ‘one-size fits all’ starting dose, without considering individual differences. This is a problem for many cancer patients as this fixed dose might be too much for an individual which could lead to adverse effects and toxicity. Similarly, the...
Autores principales: | van Leuven, Jason, Evans, Simon, Kichenadasse, Ganessan, Steeghs, Neeltje, Bonevski, Billie, Mikus, Gerd, van Dyk, Madelé |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340049/ https://www.ncbi.nlm.nih.gov/pubmed/37444404 http://dx.doi.org/10.3390/cancers15133293 |
Ejemplares similares
-
Cost-effectiveness of oral anticancer drugs and associated individualised dosing approaches in patients with cancer: protocol for a systematic review
por: van Dyk, Madelé, et al.
Publicado: (2021) -
Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias: protocol for a systematic review
por: van Dyk, Madelé, et al.
Publicado: (2022) -
Therapeutic drug monitoring of oral targeted antineoplastic drugs
por: Mueller-Schoell, Anna, et al.
Publicado: (2020) -
Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies
por: Mueller-Schoell, Anna, et al.
Publicado: (2021) -
Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups
por: Mueller-Schoell, Anna, et al.
Publicado: (2021)